Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
City of Hope, Duarte, California UCSD Moores Cancer Center, La Jolla, California Anschutz Medical Center, Aurora, Colorado UChicago Medicine Comprehensive Cancer Center, Chicago, Illinois Massachusetts General Hospital, Boston, Massachusetts Memorial Sloan Kettering Cancer Center, New York, New York